Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | NSD2 | O96028 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4217147 | 0.80 | — | — | |
| SCHEMBL5480767 | 0.72 | — | — | |
| SCHEMBL343994 | 0.72 | — | — | |
| SCHEMBL5472820 | 0.72 | — | — | |
| SCHEMBL4599615 | 0.72 | LMNA (0.36) | ALDH1A1KMT2ALMNAHPGDMEN1 | |
| SCHEMBL4598425 | 0.72 | HPGD (0.37) | ALDH1A1KDM4EKMT2ASMN1; SMN2RAB9A | |
| SCHEMBL4600271 | 0.72 | LMNA (0.42) | ALDH1A1KDM4EKMT2ASMN1; SMN2RAB9A | |
| SCHEMBL5538617 | 0.71 | SLC2A1 (0.39) | ALDH1A1KDM4EKMT2ASMN1; SMN2RAB9A | |
| SCHEMBL8152713 | 0.71 | MAOA (0.33) | — | |
| SCHEMBL4760595 | 0.69 | HDAC3 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49735-E1 | Oxazolidinones as modulators of MGLUR5 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-28 | — | — | US | claimed |
| CN-115612000-A | Infrared light sensitive photo-curing composition | 保定乐凯新材料股份有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-108351587-B | Resist composition | 曼彻斯特大学 | 2022-08-19 | — | — | CN | claimed |
| US-20210346321-A1 | PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR | CRYSTALGENOMICS, INC. (KR) | 2021-11-11 | — | — | US | claimed |
| EP-3875081-A1 | PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR | Crystalgenomics, Inc. (KR) | 2021-09-08 | — | — | EP | claimed |
| CN-113024341-A | Method for regio-and stereoselectively synthesizing (E, E) -1,4, 4-trisubstituted conjugated diene | 温州大学 | 2021-06-25 | — | — | CN | claimed |
| CN-113024342-A | Method for regio-and stereoselectively synthesizing (E) -2,4, 4-trisubstituted conjugated diene | 温州大学 | 2021-06-25 | — | — | CN | claimed |
| EP-3777847-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF FIBROSIS | Crystalgenomics, Inc. (KR) | 2021-02-17 | — | — | EP | claimed |
| US-20210015772-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF FIBROSIS | CRYSTALGENOMICS, INC. (KR) | 2021-01-21 | — | — | US | claimed |
| US-20200283371-A1 | PHARMACEUTICALLY ACCEPTABLE SALT OF ALKYLCARBAMOYL NAPHTHALENYLOXY OCTENOYLHYDROXYAMIDE OR OF DERIVATIVE THEREOF AND METHOD FOR PREPARING SAME | CRYSTALGENOMICS, INC. (KR) | 2020-09-10 | — | — | US | claimed |
| EP-0231622-A2 | Inhibition of the 5-lipoxygenase pathway | SMITHKLINE BEECHAM CORPORATION (US) | 1987-08-12 | — | — | EP | claimed |
| CN-86108538-A | The inhibition of 5-lipoxygenase pathway | — | 1987-07-29 | — | — | CN | claimed |
| EP-0184384-A1 | Substituted dihydroquinolone carboxylic acids, anti-bacterial compositions containing them | PFIZER INC. (US) | 1986-06-11 | — | — | EP | claimed |
| EP-0135711-A1 | 5-thioxo-2-imidazolinyl benzoic acids, esters, salts and related compounds, and use thereof as herbicidal agents | AMERICAN CYANAMID COMPANY (US) | 1985-04-03 | — | — | EP | claimed |
| EP-0133309-A1 | Herbicides and method for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1985-02-20 | — | — | EP | claimed |
| US-4355823-A | Pressure-sensitive or heat-sensitive recording material | CIBA-GEIGY CORPORATION (US) | 1982-10-26 | — | — | US | claimed |
| US-4331676-A | 2-PENEM COMPOUNDS UNSUBSTITUTED IN THE 6 POSITION | CIBA-GEIGY CORPORATION (US) | 1982-05-25 | — | — | US | claimed |
| US-4192868-A | ANTIINFLAMMATORY, ANALGESIC | CIBA-GEIGY CORPORATION (US) | 1980-03-11 | — | — | US | claimed |
| US-4136033-A | DIAZO COUPLERS | SANDOZ LTD. (CH) | 1979-01-23 | — | — | US | claimed |
| US-3996253-A | 2-UREIDO-PHENOLS AS COLOR COUPLERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1976-12-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210346321-A1 | PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR | AGPAT5, NOTUM, HADH | ALDH1A1 3493/4885KDM4E 2720/4885KMT2A 2545/4885 |
| US-20200283371-A1 | PHARMACEUTICALLY ACCEPTABLE SALT OF ALKYLCARBAMOYL NAPHTHALENYLOXY OCTENOYLHYDROXYAMIDE OR OF DERIVATIVE THEREOF AND METHOD FOR PREPARING SAME | DOHH, CYP51A1, CYP46A1 | ALDH1A1 690/4885KDM4E 333/4885KMT2A 397/4885 |
| US-20210015772-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF FIBROSIS | FIBP, MMP1, CFTR | ALDH1A1 761/4885KDM4E 1709/4885KMT2A 2833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.